Caplin Point Laboratories slumped 6.42% to Rs 1,365 at 13:30 IST on BSE on profit booking after surging in prior session triggered by strong Q4 results.
Meanwhile, the BSE Sensex was down 1,115.10 points, or 4.09%, to 26,245.74.
On BSE, so far 15,928 shares were traded in the counter, compared with an average volume of 10,735 shares in the past one quarter.
The stock hit a high of Rs 1,425.50 and a low of Rs 1,234 so far during the day. The stock hit a record high of Rs 1,522.75 on Friday, 21 August 2015. The stock hit a 52-week low of Rs 337 on 21 October 2014.
The stock had outperformed the market over the past one month till 21 August 2015, rising 6.85% compared with 2.9% fall in the Sensex. The scrip had also outperformed the market in past one quarter, surging 53.97% as against Sensex's 1.59% decline.
Also Read
The mid-cap company has an equity capital of Rs 15.11 crore. Face value per share is Rs 10.
Caplin Point Laboratories surged 7.66% at Rs 1,458.50 on Friday, 21 August 2015, triggered by announcing strong Q4 results. The company's consolidated net profit surged 81.8% to Rs 12.69 crore on 46.2% growth in net sales to Rs 70.13 crore in Q4 June 2015 over Q4 June 2014. The company had announced Q4 result after market hours on Thursday, 20 August 2015.
Caplin Point Laboratories currently has three fully functioning facilities and one more facility in the pipeline, capable of manufacturing a wide range of dosage forms and products catering to all segments of the pharmaceutical industry.
Powered by Capital Market - Live News
